Prevention of Rejection in Cardiac Transplantation by Blockade of the Interleukin-2 Receptor with a Monoclonal Antibody

Acute rejection episodes adversely affect short-term survival in recipients of cardiac transplants. 1 Rejection occurs most frequently during the first three months after transplantation, with the incidence decreasing exponentially thereafter. 2 Repeated or severe episodes of allograft rejection may...

Ausführliche Beschreibung